Health
Healthy Returns: A huge deal to boost Novo Nordisk’s manufacturing is one step closer to closing
A view of the logo of Novo Nordisk at the company’s office in Bagsvaerd, on the outskirts of Copenhagen, Denmark, March 8, 2024. Tom Little | Reuters A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future editions. […]
Read More
Ro to offer lower-price vials of weight loss drug Zepbound by teaming up with Eli Lilly
Patients will be able to access Zepbound single-dose vials at Ro Coutesy: Ro Direct-to-consumer health-care startup Ro on Wednesday said its platform will now offer more affordable single-dose vials of the weight loss drug Zepbound through a new partnership with Eli Lilly, which aims to streamline access to the popular treatment. Ro said it will […]
Read More
Insurance stocks have fallen since UnitedHealthcare CEO’s killing
A banner hanging from on overpass along the southbound lane of I-83 that says, “Deny Defend Depose Health Care 4 All.” Lloyd Fox | Baltimore Sun | Tribune News Service | Getty Images Major insurance stocks have fallen more than 6% since their closing prices last Tuesday, the day before the deadly shooting of Brian […]
Read More
Walgreens shares pop on report pharmacy chain could sell itself to PE firm Sycamore
People walk by a Walgreens on November 3, 2024 in Brookline, Massachusetts. Danielle DeVries | CNBC Shares of Walgreens jumped nearly 25% on Tuesday on a report that the company is in talks to sell itself to private equity firm Sycamore Partners. Walgreens and Sycamore have been discussing a deal that could be completed early […]
Read More
The weight-loss drug boom has become one of the internet’s biggest scams
A production line of Wegovy injection pens for the Asian market at the Novo Nordisk A/S pharmaceutical manufacturing facility in Hillerod, Denmark, on Wednesday, Nov. 27, 2024. Bloomberg | Bloomberg | Getty Images One interpretation of the law of supply and demand is that when demand outstrips supply, scammers get busy. That’s certainly the case […]
Read More
Judge OKs landmark class action settlement in LGBTQ fertility lawsuit
A Pride flag is seen held up in a crowd during preparation for a Queer March to the Texas State Capitol on April 15, 2023 in Austin, Texas. People from across Texas rallied together in protest against a slew of anti-LGBTQIA+ and drag bills being proposed among legislators. Brandon Bell | Getty Images A federal […]
Read More
Anthem Blue Cross Blue Shield halts anesthesia payment policy after backlash
Anthem Blue Cross Blue Shield said Thursday it was not going ahead with a policy change that would limit reimbursements for anesthesia during surgeries and medical procedures. The new policy would have reimbursed doctors based on time limits set by the insurer. Anthem BCBS, one of the largest health insurers in the U.S., quietly announced […]
Read More
Healthy Returns: Wall Street mulls over Amgen’s weight loss drug data
The Amgen logo is displayed outside Amgen headquarters in Thousand Oaks, California, on May 17, 2023. Mario Tama | Getty Images A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future editions. Wall Street is chewing over critical […]
Read More
Prescription fills for weight loss drugs Zepbound and Wegovy more than doubled in 2024, GoodRx says
A combination image shows an injection pen of Zepbound, Eli Lilly’s weight loss drug, and boxes of Wegovy, made by Novo Nordisk. Reuters Prescription fills for blockbuster weight loss drugs in the U.S. more than doubled in 2024, even with limited insurance coverage and high out-of-pocket costs for the treatments, according to data released Thursday […]
Read More
Eli Lilly’s obesity drug beats rival in head-to-head trial — where Cramer sees shares going next
New trial data has cemented Club holding Eli Lilly ‘s pole position in the highly competitive obesity drug race. The news Eli Lilly’s obesity drug Zepbound bested its main rival Wegovy — made by Denmark’s Novo Nordisk — in the first head-to-head trial comparing the fast-growing weight loss treatments. Patients on Zepound lost an average […]
Read More